Stock listing

NASDAQ:VPHM Viropharma Inc Stock

Follow Viropharma Inc into a list and get an email when it puts out news.

Last close · NASDAQ:VPHM

$49.96 USD

Close on Jan 23, 2014 · No longer trades

Jan 4, 1999 to last close +440.1% · monthly closes, Jan 4, 1999 – Jan 23, 2014
Lowest – highest close
$0.87 – $106.00 USDSince Jan 4, 1999 · lowest Oct 28, 2002 · highest Feb 23, 2000

Delisted NASDAQ:VPHM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:VPHM
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Viropharma Inc on 6ix

Decks
5 decks · latest Sep 21, 2012

Decks

DeckKindSlidesDate
Investor Day (September 2012)Investor day167 slidesSep 21, 2012
Investor Presentation (January 2010)Investor deck21 slidesJan 11, 2010
Merger or Acquisition (July 2008)Merger or acquisition29 slidesJul 15, 2008
SLIDE PRESENTATION54 slidesJan 8, 2008
Investor Day (October 2006)Investor day34 slidesOct 25, 2006

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Vincent Milano
Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Jul 26, 2021); Aclaris Therapeutics, Inc. (Director · Since at least Jan 7, 2020); Spark Therapeutics Inc (Director · Jan 29, 2015 – Dec 17, 2019 · Past); Aceragen Inc. (Director · Dec 1, 2014 – Aug 10, 2023 · Past); Vanda Pharmaceuticals Inc. (Director · Apr 21, 2010 – Jun 13, 2018 · Past)
President and CEO, Director · Jun 7, 2010 – Jan 24, 2014 · Past
John Peter Wolf III
Other companies: Nabriva Therapeutics AG (General Counsel and Corp. Sec. · Dec 30, 2016 – Dec 30, 2016 · Past); Aceragen Inc. (General Counsel · Dec 10, 2014 – Dec 10, 2014 · Past)
VP, General Counsel · Jun 10, 2013 – Jan 24, 2014 · Past
Robert PietruskoVP, Regulatory & Quality · Jun 7, 2010 – Jan 24, 2014 · Past

Open People

Log in to ask 6ix AI your own questions about Viropharma Inc.